AEGiS-CATIE: ANTI-HIV AGENTS: Saquinavir and indinavir -- some problems Canadian AIDS Treatment Information Exchange
Click here to return to CATIE main menu
DonateNow

ANTI-HIV AGENTS: Saquinavir and indinavir -- some problems

TreatmentUpdate 71, Volume 8, No 7; October 1996
Sean Hosein


In an attempt to increase the anti-HIV activity of protease inhibitors researchers are testing several drug combinations in lab experiments. At low concentrations, indinavir used with saquinavir have increased anti-HIV activity than either drug used alone. At higher concentrations the anti-HIV effects of the drugs are reduced. When technicians tested the combination against HIV that was resistant to AZT, every concentration of the 2 drugs had reduced anti-HIV activity than when each was used alone.

REFERENCES:

1. Merril DR, Manion DJ, Chou T-C, et al . Protease inhibitor combination regimens against HIV-1 in vitro. Abstract I002.


961010
CATE7107


Always watch for outdated information. This article first appeard in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1996 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284  http://www.catie.ca


This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1996. AEGIS.